ArticleCurrent oncology (Toronto, Ont.)2025

Bone Health and Endocrine Therapy with Ovarian Function Suppression in Premenopausal Early Breast Cancer: A Real-Life Monocenter Experience with Denosumab.

Angelachiara Rotondi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.